ラットモデルの世界市場：非近交系ラット、ノックアウトラット、条件付ラット...市場調査レポートについてご紹介

Table of Contents

1 Introduction
1.1 Markets Covered
1.2 Stakeholders

2 Research Methodology

3 Executive Summary

4 Market Dynamics
4.1 Drivers
4.1.1 Advances in Gene Editing Tools Set to Augment the Demand of Rat Models
4.1.2 Advantages of Rats Over Mice
4.1.3 Investments and Grants
4.1.4 Personalized Medicine to Fuel the Demand of Personalized Humanized Rat Models
4.1.5 Increase in R&D Activities of Pharmaceutical and Biotech Industries
4.2 Threats
4.2.1 Advances in Zebrafish Model Development
4.2.2 Alternative Methods to Animal Testing
4.3 Barrier
4.3.1 Regulations and Laws for Ethical Use of Animals in Research

5 Market Share Analysis, By Key Players

6 Market Size
6.1 Rat Model Market, By Type
6.1.1 Introduction
6.1.2 Inbred Rats
6.1.3 Knockout/Genetically Engineered Rats
6.1.4 Outbred Rats
6.1.5 Hybrid/Congenic Rats
6.1.6 Conditioned/Surgically Modified Rats
6.1.7 Immunodeficient Rats
6.2 Rat Model Market, By Technology
6.2.1 Introduction
6.2.2 Micro-Injection
6.2.3 Embryonic Stem Cell Injection
6.2.4 Nuclear Transferase Technology
6.2.5 Others
6.3 Rat Model Market, By Application
6.3.1 Introduction
6.3.2 Toxicology
6.3.3 Oncology
6.3.4 Immunology and Inflammation
6.3.5 Diabetes
6.3.6 Other Diseases
6.4 Rat Model Market, By Service
6.4.1 Introduction
6.4.2 Breeding
6.4.3 Cryopreservation
6.4.4 Quarantine
6.4.5 Rederivation
6.4.6 Genetic Testing
6.4.7 Model in Licensing
6.4.8 Others
6.5 Rat Care Products Market, By Type
6.5.1 Introduction
6.5.2 Cages
6.5.3 Bedding
6.5.4 Feed
6.5.5 Others

7 Geographic Analysis
7.1 Introduction
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Russia
7.3.5 Rest of Europe
7.4 Asia-Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of Asia-Pacific
7.5 Rest of World

8 Competitive Landscape
8.1 Competitive Developments Mapping
8.2 Agreement/ Collaboration/Partnership
8.3 Expansion
8.4 New Product Launch
8.5 Acquisition
8.6 Marketing and Promotion/Repositioning
8.7 Others
8.8 Empirical Assessment of Growth Strategies

9 Company Profiles
9.1 Biomedical Research Models, Inc.
9.2 Charles River Laboratories, Inc.
9.3 Covance, Inc.
9.4 Genoway S.A.
9.5 Harlan Laboratories, Inc.
9.6 Janvier Labs
9.7 Sage Labs
9.8 Taconic Biosciences, Inc.
9.9 Transposagen Biopharmaceuticals, Inc.
9.10 Transviragen, Inc.